Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Aged;; Humans;; Laryngeal Neoplasms/*pathology;; Male;; Myxoma/*pathology (1)
- Brachiocephalic vein;; EC-IC bypass;; Infratemporal approach;; Internal;; maxillary artery;; CAROTID-ARTERY;; ANEURYSMS;; REVASCULARIZATION;; SURGERY;; VEIN;; DISEASE;; GRAFTS;; FOSSA;; Clinical Neurology;; Surgery (1)
- CD4(+) T-CELLS;; DENDRITIC CELLS;; INTERLEUKIN-1 FAMILY;; SKIN;; INFLAMMATION;; DISEASE SEVERITY;; IN-VIVO;; EXPRESSION;; TOLERANCE;; IL-36;; SUPPRESSION;; Biochemistry & Molecular Biology;; Cell Biology;; Medicine (1)
- FINE-NEEDLE-ASPIRATION;; UNDETERMINED SIGNIFICANCE;; SCIENCE CONFERENCE;; FOLLICULAR LESION;; CYTOPATHOLOGY;; SYSTEM;; CYTOLOGY;; ATYPIA;; PATHOLOGISTS;; TERMINOLOGY;; Endocrinology & Metabolism (1)
- Human papillomavirus (HPV);; oropharynx;; prognostic factors;; squamous cell carcinoma (SCC);; surgery;; tonsil (1)
Articles 1 - 8 of 8
Full-Text Articles in Medicine and Health Sciences
In Reference To "The Value Of Resident Presentations At Scientific Meetings", J. A. Eloy, P. F. Svider, A. J. Folbe, M. Setzen, S. Baredes
In Reference To "The Value Of Resident Presentations At Scientific Meetings", J. A. Eloy, P. F. Svider, A. J. Folbe, M. Setzen, S. Baredes
Journal Articles
No abstract provided.
Malignancy Rate In Thyroid Nodules Classified As Bethesda Category Iii (Aus/Flus), A. S. Ho, E. E. Sarti, K. S. Jain, H. J. Wang, I. J. Nixon, A. R. Shaha, J. P. Shah, D. Kraus, R. Ghossein, L. G. T. Morris, +3 Addiltional Authors
Malignancy Rate In Thyroid Nodules Classified As Bethesda Category Iii (Aus/Flus), A. S. Ho, E. E. Sarti, K. S. Jain, H. J. Wang, I. J. Nixon, A. R. Shaha, J. P. Shah, D. Kraus, R. Ghossein, L. G. T. Morris, +3 Addiltional Authors
Journal Articles
Background: The Bethesda System for Reporting Thyroid Cytopathology is the standard for interpreting fine needle aspiration (FNA) specimens. The atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) category, known as Bethesda Category III, has been ascribed a malignancy risk of 5-15%, but the probability of malignancy in AUS/FLUS specimens remains unclear. Our objective was to determine the risk of malignancy in thyroid FNAs categorized as AUS/FLUS at a comprehensive cancer center. Methods: The management of 541 AUS/FLUS thyroid nodule patients treated at Memorial Sloan-Kettering Cancer Center between 2008 and 2011 was analyzed. Clinical and radiologic features were examined as …
Internal Maxillary Artery-Middle Cerebral Artery Bypass: Infratemporal Approach For Subcranial-Intracranial (Sc-Ic) Bypass, E. Nossek, P. Costantino, M. Eisenberg, A. R. Dehdashti, A. Setton, D. J. Chalif, R. A. Ortiz, D. J. Langer
Internal Maxillary Artery-Middle Cerebral Artery Bypass: Infratemporal Approach For Subcranial-Intracranial (Sc-Ic) Bypass, E. Nossek, P. Costantino, M. Eisenberg, A. R. Dehdashti, A. Setton, D. J. Chalif, R. A. Ortiz, D. J. Langer
Journal Articles
BACKGROUND:Internal maxillary artery (IMax)-middle cerebral artery (MCA) bypass has been recently described as an alternative to cervical extracranial-intracranial bypass. This technique uses a keyhole craniectomy in the temporal fossa that requires a technically challenging end-to-side anastomosis.OBJECTIVE:To describe a lateral subtemporal craniectomy of the middle cranial fossa floor to facilitate wide exposure of the IMax to facilitate bypass.METHODS:Orbitozygomatic osteotomy is used followed by frontotemporal craniotomy and subsequently laterotemporal fossa craniectomy, reaching its medial border at a virtual line connecting the foramen rotundum and foramen ovale. The IMax was identified by using established anatomic landmarks, neuronavigation, and micro Doppler probe (Mizuho Inc. …
Laryngeal Myxoma: A Case Report And Review Of The Literature, A. Ritchie, J. Youngerman, J. E. Fantasia, L. B. Kahn, R. S. Cocker
Laryngeal Myxoma: A Case Report And Review Of The Literature, A. Ritchie, J. Youngerman, J. E. Fantasia, L. B. Kahn, R. S. Cocker
Journal Articles
Myxomas are a rare benign neoplasm of uncertain mesenchymal cell origin, typically involving the heart. Laryngeal myxomas are uncommon, and are usually misdiagnosed as laryngeal polyp. To the best of our knowledge, there are only nine reported cases in the English literature. We report a case of a laryngeal myxoma presenting clinically as a left vocal cord polyp in a 77 year old male, and review the literature related to this rare entity.
Overexpressed Beta-Catenin Localizes To Plasma Membrane In Respiratory Papillomas, A. V. Lucs, A. L. Abramson, B. M. Steinberg
Overexpressed Beta-Catenin Localizes To Plasma Membrane In Respiratory Papillomas, A. V. Lucs, A. L. Abramson, B. M. Steinberg
Journal Articles
No abstract provided.
Early Efficacy Trial Of Anakinra In Corticosteroid-Resistant Autoimmune Inner Ear Disease, A. Vambutas, M. Lesser, V. Mullooly, S. Pathak, G. Zahtz, L. M. Rosen, E. Goldofsky
Early Efficacy Trial Of Anakinra In Corticosteroid-Resistant Autoimmune Inner Ear Disease, A. Vambutas, M. Lesser, V. Mullooly, S. Pathak, G. Zahtz, L. M. Rosen, E. Goldofsky
Journal Articles
BACKGROUND. Autoimmune inner ear disease (AIED) is a rare disease that results in progressive sensorineural hearing loss. Patients with AIED initially respond to corticosteroids; however, many patients become unresponsive to this treatment over time, and there is no effective alternative therapy for these individuals. METHODS. We performed a phase I/II open-label, single-arm clinical trial of the IL-1 receptor antagonist anakinra in corticosteroid-resistant AIED patients. Given that the etiology of corticosteroid resistance is likely heterogeneous, we used a Simon 2-stage design to distinguish between an unacceptable (= 30%) response rate to anakinra therapy. Subjects received 100 mg anakinra by subcutaneous injection …
Decreased Langerhans Cell Responses To Il-36 Gamma: Altered Innate Immunity In Patients With Recurrent Respiratory Papillomatosis, J. Devoti, L. Hatam, A. Lucs, A. Afzal, A. Abramson, B. M. Steinberg, V. Bonagura
Decreased Langerhans Cell Responses To Il-36 Gamma: Altered Innate Immunity In Patients With Recurrent Respiratory Papillomatosis, J. Devoti, L. Hatam, A. Lucs, A. Afzal, A. Abramson, B. M. Steinberg, V. Bonagura
Journal Articles
Recurrent respiratory papillomatosis (RRP) is a rare, chronic disease caused by human papillomaviruses (HPVs) types 6 and 11 that is characterized by the polarization of adaptive immune responses that support persistent HPV infection. Respiratory papillomas express elevated mRNA levels of IL-36 gamma, a proinflammatory cytokine in comparison to autologous clinically normal laryngeal tissues; however there is no evidence of inflammation in these lesions. Consistent with this, respiratory papillomas do not contain T(H)1-like CD4(+) T-cells or cytotoxic CD8(+) T-cells, but instead contain a predominance of T(H)2-like and T regulatory cells (Tregs). In addition, papillomas also are infiltrated with immature Langerhans cells …
Squamous Cell Carcinoma Of The Tonsil Managed By Conventional Surgery And Postoperative Radiation, R. Rahmati, S. Dogan, O. Pyke, F. Palmer, M. Awad, N. Lee, D. Kraus, J. P. Shah, S. G. Patel, I. Ganly
Squamous Cell Carcinoma Of The Tonsil Managed By Conventional Surgery And Postoperative Radiation, R. Rahmati, S. Dogan, O. Pyke, F. Palmer, M. Awad, N. Lee, D. Kraus, J. P. Shah, S. G. Patel, I. Ganly
Journal Articles
BACKGROUND: The purpose of this study was to report the long-term outcome of patients with squamous cell cancer (SCC) of the tonsil managed by surgery followed by postoperative radiotherapy (PORT). METHODS: Eighty-eight patients treated between 1985 and 2005 were analyzed. Overall survival (OS), disease-specific survival (DSS), and recurrence-free survival (RFS) were determined by the Kaplan-Meier method. Factors predictive of outcome were determined by univariate and multivariate analysis. RESULTS: Forty-eight percent of patients had T3 to T4 disease and 75% had a positive neck. Five-year OS, DSS, and RFS were 66%, 82%, and 80%, respectively. The status of the neck was …